Abstract:BACKGROUND For the clinical care of patients with well-established diseases, randomized trials, literature, and research are supplemented with clinical judgment to understand disease prognosis and inform treatment choices. In the void created by a lack of clinical experience with COVID-19, artificial intelligence (AI) may be an important tool to bolster clinical judgment and decision making. However, a lack of clinical data restricts the design and development of such AI tools, particularly in preparation for an impending crisis or pandemic. OBJECTIVE This study aimed to develop and test the feasibility of a “patients-like-me” framework to predict the deterioration of patients with COVID-19 using a retrospective cohort of patients with similar respiratory diseases. METHODS Our framework used COVID-19–like cohorts to design and train AI models that were then validated on the COVID-19 population. The COVID-19–like cohorts included patients diagnosed with bacterial pneumonia, viral pneumonia, unspecified pneumonia, influenza, and acute respiratory distress syndrome (ARDS) at an academic medical center from 2008 to 2019. In total, 15 training cohorts were created using different combinations of the COVID-19–like cohorts with the ARDS cohort for exploratory purposes. In this study, two machine learning models were developed: one to predict invasive mechanical ventilation (IMV) within 48 hours for each hospitalized day, and one to predict all-cause mortality at the time of admission. Model performance was assessed using the area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, positive predictive value, and negative predictive value. We established model interpretability by calculating SHapley Additive exPlanations (SHAP) scores to identify important features. RESULTS Compared to the COVID-19–like cohorts (n=16,509), the patients hospitalized with COVID-19 (n=159) were significantly younger, with a higher proportion of patients of Hispanic ethnicity, a lower proportion of patients with smoking history, and fewer patients with comorbidities ( P <.001). Patients with COVID-19 had a lower IMV rate (15.1 versus 23.2, P =.02) and shorter time to IMV (2.9 versus 4.1 days, P <.001) compared to the COVID-19–like patients. In the COVID-19–like training data, the top models achieved excellent performance (AUROC>0.90). Validating in the COVID-19 cohort, the top-performing model for predicting IMV was the XGBoost model (AUROC=0.826) trained on the viral pneumonia cohort. Similarly, the XGBoost model trained on all 4 COVID-19–like cohorts without ARDS achieved the best performance (AUROC=0.928) in predicting mortality. Important predictors included demographic information (age), vital signs (oxygen saturation), and laboratory values (white blood cell count, cardiac troponin, albumin, etc). Our models had class imbalance, which resulted in high negative predictive values and low positive predictive values. CONCLUSIONS We provided a feasible framework for modeling patient deterioration using existing data and AI technology to address data limitations during the onset of a novel, rapidly changing pandemic.

Risk Index-Based Ventilator Prediction System for COVID-19 Infection

Real-time infectious disease endurance indicator system for scientific decisions using machine learning and rapid data processing

Clinical Predictive Models for COVID-19: Systematic Study

Risk stratification and prediction of severity of COVID-19 infection in patients with preexisting cardiovascular disease

Building a COVID-19 Vulnerability Index

Predicting invasive mechanical ventilation in COVID 19 patients: A validation study

A Multi-task Gaussian Process Self-attention Neural Network for Real-time Prediction of the Need for Mechanical Ventilators in COVID-19 Patients

Development and Validation of a Deep Learning Model for Prediction of Severe Outcomes in Suspected COVID-19 Infection

Learning From Past Respiratory Infections to Predict COVID-19 Outcomes: Retrospective Study (Preprint)

Development and validation of a prediction model for mechanical ventilation based on comorbidities in hospitalized patients with COVID-19

Early ICU Mortality Prediction and Survival Analysis for Respiratory Failure

Learning From Past Respiratory Infections to Predict COVID-19 Outcomes: Retrospective Study

Estimating Risk of Mechanical Ventilation and Mortality Among Adult COVID-19 patients Admitted to Mass General Brigham: The VICE and DICE Scores

A Novel Method for Prediction and Analysis of COVID 19 Transmission Using Machine Learning Based Time Series Models

Challenges in the application of a mortality prediction model for COVID-19 patients on an Indian cohort

Development of a machine learning algorithm to predict intubation among hospitalized patients with COVID-19

Deep learning model to predict the need for mechanical ventilation using chest X-ray images in hospitalised patients with COVID-19

Machine learning algorithms for predicting determinants of COVID-19 mortality in South Africa

Evaluation of Mutual Information and Feature Selection for SARS-CoV-2 Respiratory Infection

Real-time Prediction of COVID-19 related Mortality using Electronic Health Records

A COVID-19 forecasting system for hospital needs using ANFIS and LSTM models: A graphical user interface unit